Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia (2022)
Source: Life Sciences. Unidades: FM, ICB
Subjects: FARMACOLOGIA, DOENÇAS HEMATOLÓGICAS, LEUCEMIA, LINFÓCITOS B, ONCOGENES, CÉLULAS CULTIVADAS DE TUMOR, APOPTOSE, LINFOMA, MEMBRANA PLASMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jean Carlos Lipreri da et al. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia. Life Sciences, v. 311, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2022.121146. Acesso em: 21 ago. 2024.APA
Silva, J. C. L. da, Araujo, F. S., Melo, R. C. B. de, Vicari, H. P., Carvalho, A. E. S., Rego, E. M., et al. (2022). Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia. Life Sciences, 311, 1-9. doi:10.1016/j.lfs.2022.121146NLM
Silva JCL da, Araujo FS, Melo RCB de, Vicari HP, Carvalho AES, Rego EM, Buccheri V, Machado Neto JA. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia [Internet]. Life Sciences. 2022 ; 311 1-9.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1016/j.lfs.2022.121146Vancouver
Silva JCL da, Araujo FS, Melo RCB de, Vicari HP, Carvalho AES, Rego EM, Buccheri V, Machado Neto JA. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia [Internet]. Life Sciences. 2022 ; 311 1-9.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1016/j.lfs.2022.121146